Nasonex and Application site erythema - a phase IV clinical study of FDA data

Summary:

Application site erythema is reported as a side effect among people who take Nasonex (mometasone furoate monohydrate), especially for people who are female, 60+ old, also take Singulair, and have Hypersensitivity.

The phase IV clinical study analyzes which people have Application site erythema when taking Nasonex. It is created by eHealthMe based on reports of 31,171 people who have side effects when taking Nasonex from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Application site erythema?

Application site erythema (redness of the skin at application site) is found to be associated with 670 drugs and 950 conditions by eHealthMe. Check the latest studies of Application site erythema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

31,171 people reported to have side effects when taking Nasonex.
Among them, 34 people (0.11%) have Application site erythema.

Could Nasonex cause Application site erythema?

Among these 34 people:

What is the gender of people who have Application site erythema when taking Nasonex? *

female: 64.52 %
male: 35.48 %

What is the age of people who have Application site erythema when taking Nasonex? *

What are other drugs people take besides Nasonex? *

What are other side effects people have besides Application site erythema? *

Application Site Pruritus (application site severe itching of the skin): 13 people, 38.24%
Drug Ineffective: 11 people, 32.35%
Application Site Pain: 9 people, 26.47%
Application Site Irritation: 6 people, 17.65%
Application Site Burn: 6 people, 17.65%
Itching: 5 people, 14.71%
Skin Burning Sensation: 5 people, 14.71%
Rashes (redness): 5 people, 14.71%
Pain In Extremity: 4 people, 11.76%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 11.76%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 17.65%
Hypersensitivity: 6 people, 17.65%
Asthma: 4 people, 11.76%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 11.76%
Itching: 4 people, 11.76%
High Blood Cholesterol: 3 people, 8.82%
Migraine (headache): 2 people, 5.88%
Back Pain: 2 people, 5.88%
Depression: 2 people, 5.88%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and have Application site erythema?

- Check whether Application site erythema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasonex:

Nasonex (32,299 reports)

Application site erythema treatments and more:

Application site erythema (26,658 reports)

How severe was Application site erythema and when was it recovered:

Application site erythema in Nasonex

Expand to all the drugs that have ingredients of mometasone furoate monohydrate:

Application site erythema and drugs with ingredients of mometasone furoate monohydrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Application site erythema:

Application site erythema (670 drugs)

Browse all the conditions that are associated with Application site erythema:

Application site erythema (950 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate (the active ingredients of Nasonex) and Nasonex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.